Cu( <scp>ii</scp> ) and V( <scp>iv</scp> )O complexes with tri- or tetradentate ligands based on (2-hydroxybenzyl)- <scp>l</scp> -alanines reveal promising anticancer therapeutic potential
Nádia Ribeiro(Universidade Nova de Lisboa), Isabel Correia(University of Lisbon), Carlos M. Teixeira(Instituto Politécnico de Lisboa), İpek Bulut(Koç University), Vânia André(University of Lisbon), Ceyda Açılan(Koç University), João Costa Pessoa(University of Lisbon), Yasemin Yıldızhan(Türkiye Bilimsel ve Teknolojik Araştırma Kurumu), Buse Cevatemre(Bursa Uludağ Üni̇versi̇tesi̇), Pedro Adão(Instituto Politécnico de Leiria)
Cited by 29
Related Papers
Apoptosis: why and how does it occur in biology?
|Cell Biochemistry and Function|2011|227
Synthesis, biological characterization and evaluation of molecular mechanisms of novel copper complexes as anticancer agents
|Biochimica et Biophysica Acta (BBA) - General Subjects|2016|90
DNA repair pathways involved in anaphase bridge formation
|Genes Chromosomes and Cancer|2007|63
The system VO2++oxidized glutathione: a potentiometric and spectroscopic study
|Journal of Inorganic Biochemistry|2001|58
May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
|European Journal of Medicinal Chemistry|2019|45